AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 120 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 2.28 and the average weighting 1.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2015 | $288,000 | -8.3% | 4,443 | 0.0% | 0.06% | -11.3% |
Q3 2015 | $314,000 | -36.4% | 4,443 | 0.0% | 0.07% | -23.7% |
Q2 2015 | $494,000 | +17.9% | 4,443 | 0.0% | 0.09% | +19.2% |
Q1 2015 | $419,000 | -15.9% | 4,443 | 0.0% | 0.08% | -16.1% |
Q4 2014 | $498,000 | +82.4% | 4,443 | 0.0% | 0.09% | +75.5% |
Q3 2014 | $273,000 | – | 4,443 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BB BIOTECH AG | 2,719,998 | $155,502,000 | 4.38% |
Casdin Capital, LLC | 295,000 | $16,865,000 | 4.11% |
Opaleye Management Inc. | 130,000 | $7,432,000 | 2.38% |
Opus Point Partners Management, LLC | 28,704 | $1,641,000 | 1.42% |
Fernwood Investment Management, LLC | 27,550 | $1,575,000 | 0.84% |
Rhenman & Partners Asset Management AB | 100,000 | $5,717,000 | 0.77% |
COLUMBIA WANGER ASSET MANAGEMENT LLC | 760,116 | $43,456,000 | 0.65% |
Eventide Asset Management | 214,000 | $12,234,000 | 0.64% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 262,984 | $15,035,000 | 0.59% |
CAPITAL GUARDIAN TRUST CO | 663,089 | $37,909,000 | 0.54% |